Unknown

Dataset Information

0

Relationship Between ?-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.


ABSTRACT: The evidence supporting the use of ?-blockers in patients with acute coronary syndrome after successful percutaneous coronary intervention has been inconsistent and scarce.Between March 1, 2009, and December 30, 2014, a total of 3180 eligible patients with acute coronary syndrome undergoing percutaneous coronary intervention were consecutively enrolled. The primary end point was all-cause death and the secondary end point was a composite of all-cause death, nonfatal myocardial infarction, heart failure readmission, and cardiogenic hospitalization. Patients were compared according to the use of ?-blockers at discharge. Compared with the no ?-blocker group, the risk of all-cause death was significantly lower in the ?-blocker group (hazard ratio [HR], 0.33; 95% CI, 0.17-0.65 [P=0.001]). A consistent result was obtained in multiple adjusted model and propensity score-matched analysis. The use of ?-blockers was also associated with decreased risk of composite of adverse cardiovascular events (HR, 0.47; 95% CI, 0.28-0.81 [P=0.006]), although statistical significance disappeared after multivariable adjustment and propensity score matching. Furthermore, we performed post hoc analysis for the subsets of patients and the results revealed that patients with non-ST-segment elevation myocardial infarction benefited the most from ?-blocker therapy at discharge (HR, 0.04; 95% CI, 0.00-0.27 [P=0.001]), and the use of <50% of target dose was significantly associated with better outcome compared with no ?-blocker use, rather than ?50% of target dose.The administration of relatively low ?-blocker dose is associated with improved clinical outcomes among patients with acute coronary syndrome after successful percutaneous coronary intervention, especially for patients with non-ST-segment elevation myocardial infarction.

SUBMITTER: Li C 

PROVIDER: S-EPMC5210364 | biostudies-literature | 2016 Nov

REPOSITORIES: biostudies-literature

altmetric image

Publications

Relationship Between β-Blocker Therapy at Discharge and Clinical Outcomes in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention.

Li Chenze C   Sun Yang Y   Shen Xiaoqing X   Yu Ting T   Li Qing Q   Ruan Guoran G   Zhang Lina L   Huang Qiang Q   Zhuang Hang H   Huang Jingqiu J   Ni Li L   Wang Luyun L   Jiang Jiangang J   Wang Yan Y   Wang Dao Wen DW  

Journal of the American Heart Association 20161116 11


<h4>Background</h4>The evidence supporting the use of β-blockers in patients with acute coronary syndrome after successful percutaneous coronary intervention has been inconsistent and scarce.<h4>Methods and results</h4>Between March 1, 2009, and December 30, 2014, a total of 3180 eligible patients with acute coronary syndrome undergoing percutaneous coronary intervention were consecutively enrolled. The primary end point was all-cause death and the secondary end point was a composite of all-caus  ...[more]

Similar Datasets

| S-EPMC7809633 | biostudies-literature
| S-EPMC8556441 | biostudies-literature
| S-EPMC2686264 | biostudies-other